IRIS UniCatt

Zini Tanzi, Gina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.429
NA - Nord America 5.338
AS - Asia 3.416
SA - Sud America 687
Continente sconosciuto - Info sul continente non disponibili 152
AF - Africa 96
OC - Oceania 14
Totale 15.132
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.168
DE - Germania 1.747
IT - Italia 1.446
SG - Singapore 1.437
CN - Cina 891
BR - Brasile 556
SE - Svezia 520
VN - Vietnam 355
FR - Francia 350
GB - Regno Unito 308
UA - Ucraina 285
IE - Irlanda 161
PL - Polonia 142
ID - Indonesia 138
FI - Finlandia 134
IN - India 134
NL - Olanda 79
CA - Canada 74
JP - Giappone 73
RU - Federazione Russa 72
HK - Hong Kong 70
AR - Argentina 53
TR - Turchia 53
MX - Messico 47
BE - Belgio 40
BD - Bangladesh 39
IQ - Iraq 36
ES - Italia 25
IR - Iran 23
PK - Pakistan 23
ZA - Sudafrica 22
AT - Austria 19
EC - Ecuador 18
SA - Arabia Saudita 17
CH - Svizzera 15
PE - Perù 15
CO - Colombia 14
LT - Lituania 14
AU - Australia 13
MA - Marocco 13
MY - Malesia 13
PT - Portogallo 13
CI - Costa d'Avorio 12
PH - Filippine 12
IL - Israele 11
JO - Giordania 11
KE - Kenya 11
AE - Emirati Arabi Uniti 10
KR - Corea 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
RO - Romania 9
UZ - Uzbekistan 9
CL - Cile 8
HN - Honduras 8
JM - Giamaica 8
EG - Egitto 7
DZ - Algeria 6
GE - Georgia 6
GR - Grecia 6
DO - Repubblica Dominicana 5
EE - Estonia 5
KZ - Kazakistan 5
PY - Paraguay 5
TN - Tunisia 5
YE - Yemen 5
BH - Bahrain 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
KG - Kirghizistan 4
LB - Libano 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
TW - Taiwan 4
AL - Albania 3
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
BZ - Belize 3
LV - Lettonia 3
NI - Nicaragua 3
PR - Porto Rico 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
BY - Bielorussia 2
GH - Ghana 2
GP - Guadalupe 2
GT - Guatemala 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
SV - El Salvador 2
Totale 14.957
Salva come PNG Salva come JPEG
Città #
Singapore 720
Chandler 631
Ashburn 531
San Jose 409
Beijing 193
Jacksonville 189
Ann Arbor 169
San Mateo 168
Milan 163
Dublin 160
Rome 159
Dearborn 148
Los Angeles 144
Nanjing 142
Warsaw 117
Jakarta 110
Hanoi 106
New York 104
Nürnberg 104
Ho Chi Minh City 102
Dallas 98
Lauterbourg 85
Cattolica 81
Woodbridge 81
Munich 80
Wilmington 75
Boston 70
Frankfurt am Main 68
Lawrence 65
Houston 61
Redmond 60
Tokyo 60
Fairfield 59
Seattle 58
Bremen 54
Hong Kong 54
The Dalles 54
Nanchang 51
São Paulo 51
Lancaster 49
Marseille 48
Redwood City 48
Hefei 47
Santa Clara 46
Naples 40
Brussels 38
Moscow 37
Helsinki 36
Hangzhou 35
Florence 31
London 31
Chicago 30
Bologna 29
Paris 29
Izmir 28
Norwalk 27
Boardman 26
Toronto 26
Brooklyn 25
Mountain View 25
Buffalo 24
Leawood 24
Palermo 24
Princeton 24
Rio de Janeiro 24
Shenyang 24
Orem 23
Turin 23
Zhengzhou 23
Da Nang 22
Kunming 22
Montreal 22
San Francisco 22
Shanghai 22
Tianjin 21
Turku 20
Cagliari 19
Denver 19
Jiaxing 19
Guangzhou 18
Atlanta 17
Augusta 17
Columbus 17
Hebei 17
Las Vegas 17
Baghdad 16
Düsseldorf 16
Pune 16
Haiphong 15
Mexico City 15
Cambridge 14
Falls Church 14
Philadelphia 14
University Park 14
Amsterdam 13
Genoa 13
Hyderabad 13
Johannesburg 13
Phoenix 13
Vienna 13
Totale 7.301
Salva come PNG Salva come JPEG
Nome #
MORFOLOGIA DELLE MALATTIE DEL SANGUE Verduci Editore 1.227
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 385
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 369
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 348
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features 304
Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants 299
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 292
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 242
Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants 230
Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants 222
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 212
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Weak D Type 4.2.2 (DAR1.2) in an African child: Serology and molecular characterization 203
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 198
Morphology of Blood Disorders 196
Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors 195
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 194
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 189
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 187
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 185
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 184
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 180
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors 178
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 174
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 174
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 170
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 167
Allogeneic umbilical cord blood red cell concentrates: An innovative blood product for transfusion therapy of preterm infants 165
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 163
TWO-GROUP STUDY OF MEDIAL MICROSCOPY AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS 163
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 160
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 160
Analysis of bone marrow aspiration fluid using automated blood cell counters. 159
The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy 158
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 155
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 155
Transfusion of very low birth weight neonates using allogeneic cord blood derived RBC units. 155
Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. 149
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 145
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 145
Allogeneic cord blood red cells for transfusion 144
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 142
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 141
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 136
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 135
Increased levels of solubile intercellular adhesion molecole-1, neutrophils and elastase in the lung of preterm infants with bronchopulmonary displasia. 134
Primary myelofibrosis: when the clone manifests with Rh phenotype splitting 134
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 133
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria 131
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 131
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 129
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes 128
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 128
Stability of complete blood count parameters with storage: toward defined specifications for different diagnostic applications 126
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 123
Fechtner syndrome: report of a third family and literature review 120
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions 118
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 117
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial 117
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 117
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 116
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 113
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 113
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 110
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization? 108
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 107
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 106
Medicine use in pregnancy and public cord blood bank databases 106
Fragmented red blood cells automated measurement is a useful parameter to exclude schistocytes on the blood film 104
Leukemia diagnosis: today and tomorrow 103
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 103
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas 103
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 101
Inline extracorporeal photopheresis: evaluation of cell collection efficiency 100
Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes 96
The concomitance of lymphoma and breast carcinoma in the bone 94
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance 92
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 92
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 90
Diagnostics and prognostication of myelodysplastic syndromes 89
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 87
Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia 86
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets 85
CELL-BY-CELL ASSESSMENT OF MEDIAL MICROSCOPY (MM) AS A BETWEEN-OBSERVER TOOL FOR HARMONIZATION AND PROFICIENCY TESTING (ON BEHALF OF WP10 LEUKEMIANET DIAGNOSIS MORPHOLOGICAL FACULTY) 82
Case of metastatic melanoma in bone marrow smear 79
Innovation in hematology: Morphology and flow cytometry at the crossroads 78
Four cases of transfusion-transmitted Hepatitis E virus infection: Is it time to introduce donor screening in Italy? 75
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies 72
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 70
Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients 70
Schistocytes 68
ICSH: on board for new projects 67
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 67
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 66
INTRODUCTION 62
Research in morphology and flow cytometry is at the heart of hematology 62
Totale 15.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022855 0 87 22 49 75 37 30 157 34 52 130 182
2022/20231.835 207 255 143 283 132 229 76 168 232 28 51 31
2023/2024953 54 250 33 64 48 135 86 26 22 37 102 96
2024/20252.034 44 71 147 100 216 98 91 96 277 206 391 297
2025/20264.407 707 133 262 400 687 241 832 225 285 340 178 117
2026/2027396 288 108 0 0 0 0 0 0 0 0 0 0
Totale 15.132